Clinical

Dataset Information

0

Safety and Efficacy Study of DCVax-Direct in Solid Tumors


ABSTRACT: The study comprises a Phase I component during which the optimal dose of DCVax-Direct for the treatment of solid tissue tumors will be identified, followed by a Phase II component to determine if the injection of DCVax-Direct into selected solid tissue tumors has the ability to reduce tumor growth.

DISEASE(S): Melanoma,Colorectal Cancer,Liver Cancer,Pancreatic Cancer,Locally Advanced Tumor,Neoplasms,Metastatic Solid Tissue Tumors

PROVIDER: 2147052 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-10-05 | GSE214644 | GEO
2024-02-26 | GSE254652 | GEO
2019-07-02 | PXD012728 | Pride
| PRJNA744237 | ENA
2019-07-02 | PXD012776 | Pride
2022-09-08 | GSE212703 | GEO
2010-04-13 | E-GEOD-20973 | biostudies-arrayexpress
2022-05-16 | MTBLS79 | MetaboLights
2024-03-26 | PXD041458 | Pride
2024-03-26 | PXD035951 | Pride